Effect of posttranslational modifications on the thermal stability of a recombinant monoclonal antibody
- PMID: 16831470
- DOI: 10.1016/j.imlet.2006.05.011
Effect of posttranslational modifications on the thermal stability of a recombinant monoclonal antibody
Abstract
The effect of oligosaccharides and C-terminal lysine residues on the thermal stability of a recombinant IgG(1) monoclonal antibody was investigated using differential scanning calorimetry (DSC). The C-terminal lysine did not appear to affect the thermal stability of this IgG(1) molecule. However, oligosaccharides, which are buried between the two CH(2) domains, provided significant stabilizing energy. Characterization of the Fab and Fc after papain digestion suggested that the stabilizing effect of oligosaccharides on this molecule was through stabilizing CH(2) domains. Oligosaccharides had little effect on the thermal stability of Fab region and CH(3) domains. It was also interesting to note that both intact IgG(1) antibody and its Fab, but not the Fc regions, appeared to form precipitate after thermal unfolding under the experimental conditions.
Similar articles
-
Identification of cysteinylation of a free cysteine in the Fab region of a recombinant monoclonal IgG1 antibody using Lys-C limited proteolysis coupled with LC/MS analysis.Anal Biochem. 2006 Aug 15;355(2):165-74. doi: 10.1016/j.ab.2006.05.037. Epub 2006 Jun 15. Anal Biochem. 2006. PMID: 16828048
-
[A stable conformer of IgG, prepared by an acidic influence: study by calorimetry, binding of the C1q complement component, and monospecific anti-IgG].Biokhimiia. 1994 Oct;59(10):1458-77. Biokhimiia. 1994. PMID: 7819387 Russian.
-
The unfolding/denaturation of immunogammaglobulin of isotype 2b and its F(ab) and F(c) fragments.Biophys J. 2000 Oct;79(4):2150-4. doi: 10.1016/S0006-3495(00)76462-9. Biophys J. 2000. PMID: 11023918 Free PMC article.
-
Impact of IgG Fc-Oligosaccharides on Recombinant Monoclonal Antibody Structure, Stability, Safety, and Efficacy.Biotechnol Prog. 2017 Sep;33(5):1173-1181. doi: 10.1002/btpr.2498. Epub 2017 Jun 12. Biotechnol Prog. 2017. PMID: 28547754 Review.
-
Glycosylation of recombinant antibody therapeutics.Biotechnol Prog. 2005 Jan-Feb;21(1):11-6. doi: 10.1021/bp040016j. Biotechnol Prog. 2005. PMID: 15903235 Review.
Cited by
-
Effects of glycosylation on the stability of protein pharmaceuticals.J Pharm Sci. 2009 Apr;98(4):1223-45. doi: 10.1002/jps.21504. J Pharm Sci. 2009. PMID: 18661536 Free PMC article. Review.
-
With or without sugar? (A)glycosylation of therapeutic antibodies.Mol Biotechnol. 2013 Jul;54(3):1056-68. doi: 10.1007/s12033-012-9612-x. Mol Biotechnol. 2013. PMID: 23097175 Review.
-
In-depth structural characterization of Kadcyla® (ado-trastuzumab emtansine) and its biosimilar candidate.MAbs. 2016 Oct;8(7):1210-1223. doi: 10.1080/19420862.2016.1204502. Epub 2016 Jul 5. MAbs. 2016. PMID: 27380163 Free PMC article.
-
Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies.MAbs. 2019 Jul;11(5):826-836. doi: 10.1080/19420862.2019.1608143. Epub 2019 May 8. MAbs. 2019. PMID: 30990348 Free PMC article.
-
High-throughput biophysical analysis and data visualization of conformational stability of an IgG1 monoclonal antibody after deglycosylation.J Pharm Sci. 2013 Nov;102(11):3942-56. doi: 10.1002/jps.23730. Epub 2013 Sep 24. J Pharm Sci. 2013. PMID: 24114789 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources